Thymosin Alpha 1 Peptide Buy

Posted on Category:products

Thymosin Alpha-1 10mgWe’re looking at the very best Thymosin Alpha 1 Peptide Buy and how it can be found at the most attractive price without compromising its quality. Before we dive in with the sales talk, lets first give you a full introduction to Thymosin Alpha 1 so you will be familiar with it.


What is Thymosin Alpha 1 Peptide Buy?

Maturation of T lymphocytes occurs in the thymus. Although the sequence of this process is not fully known, the participation of humoral factors in the microenvironment of this organ is accepted. In the 1960s, the end product of bovine thymus fractionation with lymphocytopoietic effects was called thymosin. However, through the advancement of laboratory methods, it was possible to distinguish different peptides within the fraction called thymosin 5. According to their isoelectric point (p I ), these peptides are classified into alpha-thymosins (p I <5.0) , beta-thymosins (p I between 5.0 and 7.0) and gamma-thymosins (p I> 7.0). The first 2 peptides recognized were alpha1-thymosin (A1-T) and beta-1 polypeptide (PPB1), which appear to lack biological activity in in vitro models of T lymphocyte maturation

Characteristics of Thymosins

PPB1 is made up of 74 amino acids. Although different effects on lymphocyte differentiation were attributed to this molecule, it was actually observed that these actions were due to the presence of endotoxins in the original bovine thymus preparations. PPB1 has now been defined as part of ubiquitin or ATP-dependent proteolysis factor 1 (APF-1). Ubiquitin is involved in the regulation of transcription, apoptosis, spermatogenesis and the degradation of cellular proteins.

What is A1-T is a 28 amino acid?

On the other hand, A1-T is a 28 amino acid peptide with a molecular mass of 3 108 Da. Molecules related to A1-T include des- (25-28) -thymosin alpha-1 and thymosin alpha-11, on the one hand, and protymosin (PRO-T), on the other. PRO-T is a 111 amino acid polypeptide that contains the complete sequence of A1-T, although it has not been determined whether a natural proteolysis process occurs that converts PRO-T to A1-T.

PRO-T and its messenger RNA

Both PRO-T and its messenger RNA have been detected in numerous tissues. Due to the distribution of the start and stop codons in the sequence of nitrogenous bases, it is presumed that PRO-T is synthesized without the formation of a precursor of larger molecular size. According to the available data, together with the genes corresponding to the light chain of myosin and ribosomal proteins, the PRO-T gene is one of the most expressed in the body. On the other hand, the existence of homologues of PRO-T in other forms of life, such as yeasts, bacteria and fish, allows us to suppose a conservation during the evolutionary process, which is attributed to the great importance of this polypeptide for prokaryotic cells and eukaryotes.

What the Authors Say

The authors recall that all mammalian PRO-T have a p Iless than 3.5, which is why it is the most acidic proteins known to date. Its high solubility in perchloric acid or in medium at high temperatures has allowed the purification of PRO-T in experimental models. The large proportion of acidic amino acids is associated with the presence of numerous negative charges and the absence of a regular secondary structure. Increased expression of PRO-T has been demonstrated in tissues with high cell proliferation, such as liver and colon carcinomas. PRO-T gene transcription is directly regulated by activated c-Myc protein. Although overexpression of PRO-T appears to be associated with the stimulation of tumor formation, its actions are linked to immunomodulation effects in in vivo models .

What Can PRO-T Do?

In another order, due to the predominance of negative charges, PRO-T can bind to cationic molecules. Divalent cations, such as zinc, stand out in this regard. The binding of this trace element with PRO-T has been shown to be linked to the structural modification of this polypeptide. It was also observed that the treatment with PRO-T in association with the administration of a diet with high zinc content caused favorable effects on the immunity in rodents with cellular immunodeficiency.

On the other hand, it is described that PRO-T can be phosphorylated in vivo , with probable predominance over glutamate or serine residues. PRO-T kinase is an enzyme present in the cytosol and its activity is greatest during the S phase of the cell cycle. The phosphorylated glutamate residues could act as energy reservoirs for different processes that occur in the cell nucleus. In this sense, the researchers recall that PRO-T is a nuclear protein involved in cell proliferation and linked to histones. It has been verified that PRO-T can interact with proteins from various viruses related to the regulatory processes of transcription and gene expression.

Levels of PRO-T

However, the presence of circulating levels of PRO-T at a concentration of 60 pM has been identified in association with A1-T originated in its metabolism, for which they have also been called “thymic hormones”. Extracellular A1-T is associated with the stimulation of endothelial cell migration, angiogenesis, and tissue repair. Likewise, this molecule is associated with the increase of receptors for interleukin 2 (IL-2) in stimulated lymphocytes and with the secretion of other cytokines such as interferon gamma. Thus, the combination of A1-T and nucleoside analogs is an investigational therapeutic alternative for chronic infection by hepatitis B and C viruses. Similarly, the co-administration of A1-T with low amounts of interferon or IL-2 seems to increase the antitumor effect of cytostatics, reducing the general toxicity of the treatment. Possible mechanisms of action of A1-T include modulation of cytokine activity or interaction with a specific receptor.

Other related molecules

Parathymosins (PTM) are molecules related to PRO-T, although there are differences in their biological function. In animal models, the presence of PTM has been identified in all tissues, with the exception of erythrocytes. Previously, an acid protein with zinc binding capacity (ZnBP) and inhibitory actions on phosphofructokinase-1 had been isolated from rodent liver preparations. By complementary DNA studies, ZnBP and PTM were confirmed to have the same structure. The interaction of PTM with the enzymes involved in carbohydrate metabolism depends on the presence of zinc, and it has been postulated that this peptide acts as a supramolecular organizer of this metabolic process.

It is pointed out that PTM is distributed in the cytosol or in the cell nucleus in a different way for each tissue, depending on the proliferation and differentiation indices of the cells that comprise it. Thus, in resting cells, PTM predominates in the cytosol, with partial inhibition of phosphofructokinase activity. During the proliferation stage, the need for ATP increases, for which glucose is metabolized anaerobically with the production of lactate. In this context, PTM translocates to the cell nucleus to bind with histone A1 and stimulate DNA replication, and inhibition of glucose metabolism is suppressed.

In another order, the researchers add that PTM is characterized by inhibition of glucocorticoid receptor binding to the cell nucleus. This process does not appear to depend on the presence of zinc as a cofactor. Because corticosteroids decrease cell proliferation and increase differentiation, PTM could stimulate proliferation rates in different cells.

On the other hand, beta-thymosins are peptides isolated from the purification of the thymosin 5 fraction. Although numerous variants of these molecules have been identified in the animal kingdom, a predominance of the beta-4 peptide is observed in mammals. Beta-thymosins are present in most tissues, with the exception of red blood cells, and their high intracellular concentration suggests their participation in general cellular functions. However, the amino acid sequence of beta-4-thymosin has been shown to be identical to that of actin-sequestering peptide. Thus, the formation of molecular complexes between G-actin and beta-4-thymosin is described. Therefore, modifications in the amino acid chain of this thymosin can induce alterations in the affinity for G-actin. Coincidentally, the existence of interactions between beta-4-thymosin and the filamentous form of actin is mentioned. However, it is noted that beta-thymosins could be linked to carcinogenesis because these molecules could provide G-actin to tissues that actually require the filamentous form of the protein.

The expression of beta-10-thymosin is observed to be increased in various in vitro models of neoplasms in humans. These levels seem to be related to the alterations of the blood vessels in the presence of cancer. Coincidentally, in experiments with animals, it has been described that beta-15-thymosin acts as a regulator of tumor cell motility and could constitute a biomarker in different carcinomas.

Likewise, beta-thymosins participate in angiogenesis and tissue repair, with actions on the differentiation of endothelial cells. Its effects on reducing inflammation and stimulating healing have been demonstrated in in vitro and in vivo models , for which the FDA has authorized phase 1 studies to evaluate the usefulness of beta-4-thymosin. in the treatment of wounds.

On the other hand, it was described that the AcSDKP tetrapeptide, linked to the regulation of hematopoiesis, is a probable metabolite of beta-4-thymosin produced by the activity of a protease not yet identified. The AcSDKP peptide is associated both with the inhibition of the growth of cell progenitors in the bone marrow and with presumed regulatory actions of the spermatogenesis process. AcSDKP is reported to be metabolized by angiotensin converting enzyme 1 (ACE). Therefore, the concentration of this peptide is elevated in subjects receiving ACE inhibitors, which may be associated with partial resistance to erythropoietin treatment.


A1-T is a peptide that originates from a higher molecular mass polypeptide called PRO-T, which is characterized by numerous biological activities related to gene transcription and chromatin remodeling, among others. Both the circulating forms of A1-T and PRO-T are involved in the regulation of angiogenesis and cell migration. On the other hand, PTMs are molecules that, in the presence of zinc, are associated with the regulation of carbohydrate metabolism and with DNA replication, depending on their intracellular location.

In relation to beta-thymosins, their activity as G-actin sequestering peptides has been described and, consequently, they intervene in the microfilament cell system. Increased expression of beta-thymosins is a characteristic of different malignancies; likewise, its activity on angiogenesis and healing constitutes a promising goal for research.